Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Omada Health, Inc. has received a consensus recommendation of "Moderate Buy" from analysts, with an average 1-year price target of $25.00.
• The company reported a quarterly loss of ($0.22) EPS, which was below analysts’ expectations, but achieved revenue of $61.37 million, exceeding the consensus estimate.
• Several hedge funds have recently acquired new stakes in Omada Health, with total investments ranging from $32,000 to $458,000 during the second quarter.

Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the ten analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $25.00.

OMDA has been the topic of several research analyst reports. Robert W. Baird initiated coverage on Omada Health in a research note on Friday, September 5th. They issued a "neutral" rating and a $24.00 price objective on the stock. Baird R W raised Omada Health to a "hold" rating in a research note on Friday, September 5th. Needham & Company LLC raised their price objective on Omada Health from $23.00 to $24.00 and gave the company a "buy" rating in a research note on Friday, August 8th. JPMorgan Chase & Co. initiated coverage on Omada Health in a research note on Tuesday, July 1st. They issued an "overweight" rating and a $19.00 price objective on the stock. Finally, Canaccord Genuity Group raised their price objective on Omada Health from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Friday, August 8th.

Institutional Trading of Omada Health

Hedge funds have recently made changes to their positions in the company. Raymond James Financial Inc. acquired a new stake in shares of Omada Health during the second quarter valued at about $32,000. Ilex Capital Partners UK LLP acquired a new stake in shares of Omada Health during the second quarter valued at about $201,000. Sandia Investment Management LP acquired a new stake in shares of Omada Health during the second quarter valued at about $366,000. XTX Topco Ltd acquired a new stake in shares of Omada Health during the second quarter valued at about $414,000. Finally, Walleye Capital LLC acquired a new stake in shares of Omada Health during the second quarter valued at about $458,000.

Omada Health Trading Up 2.9%

Shares of NASDAQ OMDA opened at $23.98 on Thursday. Omada Health has a 52 week low of $14.14 and a 52 week high of $28.40. The stock has a fifty day moving average of $21.78.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.07). The company had revenue of $61.37 million during the quarter, compared to the consensus estimate of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.